Diagnosis and Treatment of Central Line-Associated Bloodstream Infection (CLABSI)

Diagnostic Criteria for CLABSI

The definitive diagnosis of CLABSI requires either growth of the same organism from both a peripheral blood culture and catheter tip culture, or growth of the same organism from both catheter-drawn and peripheral blood cultures with specific quantitative differences or time to positivity differences 1, 2
CLABSI is defined as a primary bloodstream infection in a patient who had a central venous catheter (CVC) within 48 hours before the development of the infection, not related to infection at another site 3
When the interval between infection onset and device use is >48 hours, there must be compelling evidence linking the infection to the central catheter 3

Definitive Diagnostic Methods

Catheter tip culture with peripheral blood culture: Growth of the same organism from at least one peripheral blood culture and from the catheter tip culture 1, 2
Paired blood cultures with quantitative analysis: Growth of the same organism from catheter-drawn and peripheral blood samples with colony count from catheter hub at least 3-fold greater than from peripheral vein 1, 4
Differential time to positivity (DTP): Growth of the same organism from catheter-drawn blood at least 2 hours before growth is detected in peripheral blood sample 1, 2

Blood Culture Collection Technique

Obtain blood cultures before initiating antimicrobial therapy 1, 2
Draw paired blood samples from the catheter and a peripheral vein 1, 4
Properly disinfect catheter hub with alcohol, alcoholic chlorhexidine (>0.5%), or tincture of iodine 1, 2

Treatment of CLABSI

Empiric Antimicrobial Therapy

Start empiric therapy after obtaining blood cultures when CLABSI is suspected 1, 5
Use vancomycin for empiric coverage of gram-positive organisms in settings with elevated MRSA prevalence 1, 5
Include gram-negative coverage based on local susceptibility patterns (e.g., fourth-generation cephalosporin, carbapenem, or β-lactam/β-lactamase combination) 1, 5

Catheter Management

Remove non-tunneled CVCs in cases of evident local infection at exit site, clinical signs of sepsis, positive culture of catheter exchanged over guidewire, or positive paired blood cultures 6, 7
Long-term catheters should be removed with severe sepsis, suppurative thrombophlebitis, endocarditis, or persistent bloodstream infection despite appropriate antimicrobial therapy 5

Duration of Antimicrobial Therapy

Day 1 of therapy is considered the first day on which negative blood culture results are obtained 1, 5
For uncomplicated CLABSI with catheter removal: 10-14 days of antimicrobial therapy 1
For persistent bacteremia or fungemia (>72h after catheter removal): 4-6 weeks of therapy 5

Risk Factors and Prevention

Risk Factors for CLABSI

Duration of catheterization (>1 week significantly increases risk) 8
Catheter site (femoral and jugular sites have higher infection rates than subclavian) 8
Use of catheter for parenteral nutrition 8

Prevention Strategies

Select optimal insertion site (subclavian preferred over jugular or femoral) 8
Use maximal sterile barrier precautions during insertion 8
Implement proper hand hygiene 8
Use >0.5% chlorhexidine with alcohol for skin antisepsis 8
Apply sterile, transparent dressings and change according to protocol 9
Choose catheters with minimum number of lumens necessary 8
Consider antimicrobial-impregnated catheters for high-risk patients 8
Maintain adequate nurse-to-patient ratio in ICUs 9
Apply chlorhexidine-containing dressings for patients over two months of age 9

Blood Culture Sampling from Multiple Lumens in Suspected CRBSI

Primary Diagnostic Approach: Peripheral + Central Sampling

The Infectious Diseases Society of America recommends drawing paired blood cultures simultaneously from one catheter lumen and a peripheral vein before starting antibiotics, allowing for quantitative comparison or differential time to positivity to confirm CRBSI 10, 11, 12

When Peripheral Access is Unavailable

The Infectious Diseases Society of America suggests drawing blood cultures from at least 2 different catheter lumens, with a Grade B-III recommendation, when peripheral access is unavailable 10, 11, 12
The IDSA guidelines acknowledge that it is unclear whether blood cultures should be drawn through all catheter lumens in such circumstances, with a Grade C-III recommendation 10, 11, 12

Practical Algorithm

The recommended step 1 is to attempt peripheral venous blood culture + one central line culture, preferably from the lumen used for parenteral nutrition and blood products if multi-lumen 10, 11
The recommended step 2 is to draw from ≥2 different catheter lumens if peripheral access is impossible 10, 11, 12

Critical Technical Points

The Infectious Diseases Society of America recommends cleaning catheter hubs meticulously with alcohol, alcoholic chlorhexidine (>0.5%), or tincture of iodine before drawing 10, 12
The Infectious Diseases Society of America suggests labeling bottles clearly to indicate which lumen/site each sample came from 10, 11
The Infectious Diseases Society of America recommends obtaining all cultures before initiating antimicrobial therapy 10, 11

Common Pitfalls to Avoid

The Infectious Diseases Society of America advises against routinely culturing all lumens as standard practice, as the evidence does not support this and it increases cost without proven benefit 10, 11, 12

Guidelines for Blood Specimen Collection from PICC Lines

Preparation and Hand Hygiene

Hub Disinfection

Blood Draw Technique

Special Considerations When CRBSI Is Suspected

Critical Pitfalls to Avoid

Infection Mechanism Insight

Diagnostic Criteria and Laboratory Techniques for Catheter‑Related Bloodstream Infection (CRBSI)

Definitive Diagnostic Criteria

CRBSI is definitively diagnosed when the same organism is isolated from a peripheral blood culture and either a catheter tip culture (≥15 CFU by semiquantitative roll‑plate or ≥10² CFU by quantitative sonication) or from paired blood cultures that meet quantitative thresholds while the catheter remains in place【17】.

Catheter Tip Culture Methods

Short‑term catheters (< 14 days)

The semiquantitative roll‑plate technique is the standard method; a culture is considered positive when >15 CFU are recovered from a 5‑cm catheter segment【17】【18】.

Long‑term catheters (≥ 14 days)

Quantitative methods (e.g., sonication) are more sensitive than roll‑plate because intraluminal colonization predominates; a culture is positive when >10² CFU are recovered【17】【18】.

Subcutaneous ports

Both the port reservoir contents and the catheter tip should be cultured, with the reservoir culture providing higher sensitivity【17】【18】.

Pulmonary artery catheters

The introducer tip, rather than the catheter itself, should be cultured to achieve a higher diagnostic yield【17】【18】.

Antimicrobial‑coated catheters

Specific inhibitors must be added to culture media to prevent false‑negative results caused by antimicrobial coatings【17】【18】.

Blood Culture Collection Technique

Blood cultures should be obtained before initiating antimicrobial therapy【17】【19】.
The catheter hub must be meticulously cleaned with alcohol, alcoholic chlorhexidine (> 0.5 %), or tincture of iodine prior to sampling【17】.

Clinical Interpretation of Findings

Fever is highly sensitive but poorly specific for CRBSI【17】【18】.
Purulence or inflammation at the insertion site has higher specificity but low sensitivity【17】【18】.
Isolation of Staphylococcus aureus, coagulase‑negative staphylococci, or Candida species from blood cultures without another identifiable source should raise strong suspicion for CRBSI【17】【18】.
When the catheter exit site shows purulent drainage, a swab for culture and Gram stain is recommended【17】【18】.
For long‑term catheters, growth of < 15 CFU/plate of the same organism from both the insertion‑site culture and the catheter‑hub culture strongly suggests the catheter is not the infection source【17】【18】.

Common Laboratory Pitfalls

Qualitative broth cultures of catheter tips are not recommended because they lack specificity【17】【18】.
Routine catheter tip cultures upon removal are discouraged unless CRBSI is specifically suspected【17】.

Diagnostic Criteria for Catheter‑Related Bloodstream Infection (CRBSI)

Definitive Diagnostic Criteria

A CRBSI is confirmed when the same organism grows from a peripheral blood culture and either (1) a catheter‑tip culture showing ≥15 CFU by semiquantitative roll‑plate or ≥100 CFU by quantitative sonication, or (2) paired blood cultures with a ≥3‑fold higher colony count from the catheter hub than from a peripheral vein, or a differential time to positivity (DTP) of ≥2 h earlier growth from the catheter hub. 20, 21, 22

Blood‑Culture Collection Technique

Obtain paired blood samples simultaneously before any antimicrobial therapy—one from the catheter hub and one from a peripheral vein—and clearly label each bottle with its source. 21, 22
Clean the catheter hub with alcohol, alcoholic chlorhexidine (>0.5 %), or tincture of iodine and allow ≈30 seconds for complete drying before drawing cultures. 21, 22
For peripheral blood draws, use the same antiseptic preparation with adequate skin contact and drying time. 22
If peripheral venipuncture is impossible, draw blood cultures from at least two different catheter lumens; evidence supporting this practice is limited. 21, 22

Quantitative Diagnostic Methods (Catheter Left In Situ)

A colony count from the catheter hub that is ≥3‑fold greater than the count from peripheral blood definitively establishes CRBSI. 21, 22
A DTP of ≥2 hours (microbial growth from catheter‑drawn blood at least 2 h before peripheral blood) confirms CRBSI. 21, 22

Catheter‑Tip Culture Methods (Catheter Removed)

Short‑term catheters (<14 days): Use the semiquantitative roll‑plate technique; growth of >15 CFU from a 5‑cm segment indicates catheter colonization. 20, 22
Long‑term catheters (≥14 days): Quantitative methods (e.g., sonication) are more sensitive; growth of >100 CFU confirms colonization. 20
Subcutaneous ports: Culture both the port reservoir contents and the catheter tip; the reservoir provides higher diagnostic sensitivity than tip culture alone. 20, 22
Pulmonary artery catheters: Culture the introducer tip rather than the catheter itself for higher diagnostic yield. 20, 22
Antimicrobial‑coated catheters: Add specific inhibitors to culture media to prevent false‑negative results. 20

Clinical Findings and Interpretation

Fever is highly sensitive but poorly specific for CRBSI. 20
Purulence or inflammation at the insertion site has higher specificity but low sensitivity. 20
Blood cultures positive for Staphylococcus aureus, coagulase‑negative staphylococci, or Candida species without another identifiable source should strongly raise suspicion for CRBSI. 20
When purulent drainage is present at the catheter exit site, obtain a swab for culture and Gram staining. 20, 22
For long‑term catheters, growth of <15 CFU/plate of the same organism from both insertion‑site and catheter‑hub cultures suggests the catheter is not the infection source. 20, 22

Management Recommendations

Empirical Antimicrobial Therapy

Initiate empirical antibiotics immediately after obtaining blood cultures when CRBSI is suspected. 22
Use vancomycin for gram‑positive coverage in healthcare settings with elevated MRSA prevalence. 21, 22
If MRSA isolates have a vancomycin MIC > 2 µg/mL, substitute with agents such as daptomycin. 21, 22
Do not use linezolid for empirical therapy in patients with suspected but unproven bacteremia. 21, 22
Provide gram‑negative coverage based on local susceptibility patterns using a fourth‑generation cephalosporin, carbapenem, or β‑lactam/β‑lactamase inhibitor combination. 21, 22
For femoral catheters in critically ill patients, add empirical coverage for Candida species. 21

Definition of Therapy Day 1

Day 1 of therapy is defined as the first day on which negative blood‑culture results are obtained. 21, 22

Common Pitfalls to Avoid

Do not use qualitative broth cultures of catheter tips; they lack specificity and are not recommended. 20, 22
Do not routinely culture catheter tips upon removal unless CRBSI is specifically suspected. 20
Do not routinely obtain “test‑of‑cure” blood cultures after completing therapy; evidence supporting this practice is insufficient. 21, 22